𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection

✍ Scribed by Jeroen N. Stoop; Renate G. van der Molen; Carla C. Baan; Luc J. W. van der Laan; Ernst J. Kuipers; Johannes G. Kusters; Harry L. A. Janssen


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
184 KB
Volume
41
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


Chronic hepatitis B virus (HBV) infection is characterized by a weak immune response to HBV. Regulatory T cells (T(reg)) can suppress the function of effector T cells and may thus be key players in this impaired immune response. Changes in the functionality or number of T(reg) could explain the decreased antiviral response in chronic HBV patients. To investigate the role of T(reg) in chronic HBV infection, we compared the proportional frequency and functionality of T(reg) in peripheral blood of 50 chronic HBV patients, 23 healthy controls, and 9 individuals with a resolved HBV infection. A higher percentage of T(reg), defined as CD4, CD25, CD45RO, and cytotoxic T-lymphocyte-associated antigen 4-positive cells, was detected within the population of CD4(+) cells in peripheral blood of chronic HBV patients compared with healthy controls and individuals with a resolved HBV infection. Accordingly, chronic HBV patients displayed a higher FoxP3 messenger RNA level than healthy controls. Depletion of CD25(+) cells from peripheral blood mononuclear cells (PBMC) of chronic HBV patients resulted in an enhanced proliferation after stimulation with HBV core antigen. Reconstitution of these depleted PBMC with CD4(+)CD25(+) T(reg) resulted in a dose-dependent reduction of both HBV-specific proliferation and interferon gamma production. In conclusion, chronic HBV patients harbor an increased percentage of T(reg) in peripheral blood compared with controls. T(reg) have an immunosuppressive effect on HBV-specific T helper cells. The presence of HBV-specific T(reg) could contribute to an inadequate immune response against the virus, leading to chronic infection.


πŸ“œ SIMILAR VOLUMES


T- and B-cell responses to different hep
✍ M Lechmann; H G Ihlenfeldt; I Braunschweiger; G Giers; G Jung; B Matz; R Kaiser; πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 244 KB πŸ‘ 1 views

Β¨b-37 months [range, 28 months-23 years] as documented by the first ingen, Tu Β¨bingen, Germany.

Cellular immunity to hepatitis C virus c
✍ Juan-JosΓ© Lasarte; Marta GarcΓ­a-Granero; AscensiΓ³n LΓ³pez; Noelia Casares; NicolΓ‘ πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 233 KB πŸ‘ 2 views

To investigate the involvement of T-cell response against hepatitis C virus (HCV) antigens in viral clearance after interferon therapy, we measured interleukin-2 (IL-2) production by peripheral mononuclear cells in response to HCV core in patients with chronic hepatitis C. In a cohort of 43 patients

Clonal B cell populations in the blood a
✍ Laurent Vallat; Yves Benhamou; Maya Gutierrez; Pascale Ghillani; Christel Herche πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 111 KB πŸ‘ 2 views

## Abstract ## Objective The association of hepatitis C virus (HCV) infection with type II mixed cryoglobulinemia is well established, but the role of HCV in B cell lymphoma remains controversial. The objective of this study was to determine the frequency of circulating and liver‐infiltrating mono